U.S. Bodily Remedy (USPH) got here out with quarterly earnings of $0.65 per share, lacking the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.59 per share a yr in the past. These figures are adjusted for non-recurring gadgets.
This quarterly report represents an earnings shock of -12.16%. 1 / 4 in the past, it was anticipated that this doctor staffing providers firm would submit earnings of $0.68 per share when it truly produced earnings of $0.69, delivering a shock of 1.47%.
Over the past 4 quarters, the corporate has surpassed consensus EPS estimates simply as soon as.
U.S. Bodily Remedy
The sustainability of the inventory’s fast worth motion based mostly on the recently-released numbers and future earnings expectations will principally rely upon administration’s commentary on the earnings name.
U.S. Bodily Remedy shares have misplaced about 0.7% for the reason that starting of the yr versus the S&P 500’s achieve of 1.3%.
What’s Subsequent for U.S. Bodily Remedy?
Whereas U.S. Bodily Remedy has underperformed the market to this point this yr, the query that involves traders’ minds is: what’s subsequent for the inventory?
There are not any simple solutions to this key query, however one dependable measure that may assist traders handle that is the corporate’s earnings outlook. Not solely does this embody present consensus earnings expectations for the approaching quarter(s), but additionally how these expectations have modified these days.
Empirical analysis exhibits a robust correlation between near-term inventory actions and developments in earnings estimate revisions. Traders can monitor such revisions by themselves or depend on a tried-and-tested ranking device just like the Zacks Rank, which has a powerful monitor report of harnessing the facility of earnings estimate revisions.
Forward of this earnings release, the estimate revisions pattern for U.S. Bodily Remedy: blended. Whereas the magnitude and path of estimate revisions may change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #3 (Maintain) for the inventory. So, the shares are anticipated to carry out in keeping with the market within the close to future. You may see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Will probably be attention-grabbing to see how estimates for the approaching quarters and present fiscal yr change within the days forward. The present consensus EPS estimate is $0.66 on $171.75 million in revenues for the approaching quarter and $2.93 on $730.44 million in revenues for the present fiscal yr.
Traders must be conscious of the truth that the outlook for the business can have a cloth affect on the efficiency of the inventory as effectively. By way of the Zacks Business Rank, Medical – Outpatient and Dwelling Healthcare is at the moment within the high 24% of the 250 plus Zacks industries. Our analysis exhibits that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.
One other inventory from the identical business, RadNet (RDNT), has but to report outcomes for the quarter ended December 2024. The outcomes are anticipated to be launched on February 28.
This operator of medical diagnostic imaging facilities is predicted to submit quarterly earnings of $0.15 per share in its upcoming report, which represents a year-over-year change of -25%. The consensus EPS estimate for the quarter has remained unchanged over the past 30 days.
RadNet’s revenues are anticipated to be $458.06 million, up 9% from the year-ago quarter.
Ought to You Put money into U.S. Bodily Remedy, Inc. (USPH)?
Earlier than you spend money on U.S. Bodily Remedy, Inc. (USPH), need to know the most effective shares to purchase for the following 30 days? Try Zacks Funding Analysis for our free report on the 7 best stocks to purchase.
Zacks Funding Analysis has been dedicated to offering traders with instruments and impartial analysis since 1978. For greater than 1 / 4 century, the Zacks Rank stock-rating system has greater than doubled the S&P 500 with a mean achieve of +24.08% per yr. (These returns cowl a interval from January 1, 1988 via Might 6, 2024.)
U.S. Physical Therapy, Inc. (USPH) : Free Stock Analysis Report
RadNet, Inc. (RDNT) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
